LOCASALENE 0.2 MG/G CREAM

LOCASALENE 0.2 MG/G CREAM
Product Description

It is used in subacute and chronic inflammatory skin diseases that respond to corticosteroids, especially with hyperkeratosis.

Avixa Ilac San ve Tic Ltd Sti

  • TR
  • 2022
    On CPHI since
  • 50 - 99
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Specifications
  • CAS Registry Number
    2020/119
  • Selling Points
    Brand Name; International Approvals/Standards; Packaging; Place of Origin; Price; Quality Service
  • Model
    CREAM
  • Supplied from
    Türkiye
  • Measured In
    g

Avixa Ilac San ve Tic Ltd Sti

  • TR
  • 2022
    On CPHI since
  • 50 - 99
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

More Products from Avixa Ilac San ve Tic Ltd Sti (4)

  • BENPAIN

    Product BENPAIN

    Benpain (Benzydamine HCl) Mouthwash% 0,15; 120ml Benpain  (Benzydamine HCl) Oral Spray % 0,15;  30 ml
  • CLOFAST

    Product CLOFAST

    CLOFAST, “non-steroidal anti-inflammatory drugs used in the treatment of pain and inflammation”
  • NASOVINE DUO

    Product NASOVINE DUO

    NASOVINE DUO 0.5 MG + 0.6 MG/ML NOSE SPRAY, SOLUTION Equivalents (drugs containing the active ingredient Ipratropium bromide + xylometazoline) 

    Blocked and runny nose treatment.  (The xylometazoline helps to open up and clear nasal passages by reducing swollen blood vessels and the ipr...
  • SIFLOKS

    Product SIFLOKS

    Ciprofloxacin 500 mg,  14Tablet

Avixa Ilac San ve Tic Ltd Sti resources (1)

  • Brochure PRODUCT CATALOG

    Avixa Pharmaceuticals started its sectoral activities in 1981 with a pharmacy and a chemical raw material production facility. In 2010s, we become a group of companies including pharmacy, pharmaceutical warehouse, pharmaceutical company and R&D company, all located in Istanbul, Türkiye.

    Avixa Pharmaceuticals have missions to developing the best and innovative products to need of all patients, making all the necessary investments in it, keeping the satisfaction of the patients at the highest level and adhering to legal and ethical values at all times without compromising quality and human health priority.

    We have a vision to produce world-class drugs, discover new treatment solutions, and become a trusted company with a wide product portfolio, recognized and appreciated throughout the world with a solid and permanent infrastructure.